Safety Study of Abatacept in Rheumatoid Arthritis Participants

A Post-marketing Study to Assess the Safety of Abatacept in Sweden Using the Swedish Rheumatology Quality Register (SRQ) Register

NCT05413044 ·Status: COMPLETED

A Study of Juvenile Idiopathic Arthritis Patients Given Abatacept and the Number of Infections or Malignancies That Occur

NCT03769558 ·Status: COMPLETED

Post-marketing Study Assessing the Long-Term Safety of Abatacept

NCT02169544 ·Status: COMPLETED

Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy

NCT00124982 ·Status: COMPLETED ·Phase: PHASE3

Effects of Abatacept in Patients With Early Rheumatoid Arthritis

NCT02504268 ·Status: COMPLETED ·Phase: PHASE3

A Phase III Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis

NCT00048932 ·Status: COMPLETED ·Phase: PHASE3

A Phase III Study of Abatacept (BMS-188667) in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate

NCT00048568 ·Status: COMPLETED ·Phase: PHASE3

Benefits of Injectable Abatacept Using Magnetic Resonance Imaging (MRI) in Rheumatoid Arthritis (RA) Patients

NCT01351480 ·Status: COMPLETED ·Phase: PHASE3

A Study to Compare the Response to Treatment With Abatacept vs Adalimumab, on Background Methotrexate, in Adults With Early, Seropositive, and Shared Epitope-positive Rheumatoid Arthritis and an Inadequate Response to Methotrexate

NCT04909801 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Abatacept Versus Adalimumab Head-to-Head

NCT00929864 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety and Efficacy of Rituximab in Combination With Methotrexate Compared to Methotrexate Alone in Patients With Active Rheumatoid Arthritis

NCT00299130 ·Status: COMPLETED ·Phase: PHASE3

Efficacy, Pharmacokinetics, Safety, and Immunogenicity Study of Abatacept Administered Subcutaneously to Treat Rheumatoid Arthritis in Japanese Patients

NCT01001832 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Effects of Abatacept on Myocarditis in Rheumatoid Arthritis

NCT03619876 ·Status: TERMINATED ·Phase: PHASE4

Pharmacokinetics, Safety and Tolerability Study of Single Dose of Abatacept 125mg Administered Subcutaneously

NCT02805010 ·Status: UNKNOWN ·Phase: PHASE1

Study to Assess Changes in the Immune Profile in Adults With Early Rheumatoid Arthritis

NCT02557100 ·Status: COMPLETED ·Phase: PHASE4

Remission and Joint Damage Progression in Early Rheumatoid Arthritis

NCT00122382 ·Status: COMPLETED ·Phase: PHASE3

A Phase III Study of Abatacept in Japanese Subjects With Rheumatoid Arthritis

NCT00484289 ·Status: COMPLETED ·Phase: PHASE3

Impact of Subcutaneous Abatacept in Rheumatoid Arthritis Assessing Inhibition of Structural Damage

NCT01333878 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Safety Study of Abatacept in Sweden

NCT01094795 ·Status: COMPLETED

Long-Term Outcomes With Abatacept In Biologic Treatment-Naive Rheumatoid Arthritis Patients In Japanese Clinical Practice Settings

NCT02758769 ·Status: COMPLETED

A Phase III Study of Abatacept in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate

NCT00409838 ·Status: COMPLETED ·Phase: PHASE3

Abatacept and Infliximab in Combination With Methotrexate in Subjects With Rheumatoid Arthritis

NCT00095147 ·Status: COMPLETED ·Phase: PHASE3

A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate

NCT02629159 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Adults With Rheumatoid Arthritis

NCT02049138 ·Status: COMPLETED ·Phase: PHASE2

Does Abatacept Induce Regulatory B Cells in Patients With Rheumatoid Arthritis

NCT02885818 ·Status: COMPLETED